pharmaphorum

MAY 25, 2021

We are doing that with a good number of rare diseases already both in respiratory diseases and neurology with different life sciences companies in different countries.”. BREATHE’s Jenni Quint said that the power is not just in information from wearables but the ability to link them with other data. About BREATHE.

Big Data 135

Big Data Clinical Research Research Trials 135

XTalks

JULY 24, 2024

XTALKS WEBINAR: Digital Health Tools That Will Transform Cancer Treatment Live and On-Demand: Thursday, August 22, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn how pharmaceutical and life science technology companies are collaborating to harness digital health tools in oncology care delivery. Nanostics Inc.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

APRIL 8, 2022

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 65

Genome Genomics Research Big Data 65

pharmaphorum

MAY 30, 2022

“We can couple that with claims data and directly look at healthcare resource utilisation and see which doctors patients are visiting and if they are going to the emergency room or urgent care because of pain,” Sackman states. He oversees operations, including business development, sales and marketing, and people.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Big Data 96

pharmaphorum

JULY 4, 2022

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.

Genome 105

Genome Genomics Research Medicine 105

pharmaphorum

MARCH 16, 2021

By extracting and reading unstructured information buried within the free text of clinical notes, Savana’s technology and clinical research methodology is enabling clinicians and health researchers around the world to analyse vast amounts of previously inaccessible clinical data. “We Fragmentation of information is our enemy.

Doctor 115

Doctor Doctors Life Science Clinical Research 115